Application Deadline: 06/03/2016
Ref: TR-GG
El grup de Caracterització Bioelèctrica a la Nanoescala de l’Institut de Bioenginyeria de Catalunya (IBEC) requereix incorporar un/a Tècnic de Suport a la Recerca per a realitzar un treball de col·laboració amb el grup de Biofísica de Biomembranes de la Universitat de Barcelona, dins el marc del Grup de Recerca Consolidat en Nanobioenginyeria i Bioelectrònica.
The General Assembly of HealthTech Cluster, a consortium of companies, hospitals and research centres, including IBEC, took place at the UPC’s Campus Nord yesterday.The meeting approved HealthTech Cluster’s strategic plan for 2016, with some of the main working groups focused on will be innovation, internationalisation and networking. The programme of presentations included IBEC Associated Researcher Alicia Casals, who gave a talk entitled “Robòtica Intel·ligent i Sistemes Assistencials“, and there was also a visit to her laboratory afterwards.
HealthTech Cluster was launched in July 2014 by ACCIO to promote the competitiveness of health technologies in Catalonia.
IBEC Director Josep Samitier gives his expert opinion in an El Español article about the future of 3D printing applied to biomedicine.Multifunctional molecular nanovesicles: A new challenge for drug delivery
Multifunctional molecular nanovesicles: A new challenge for drug delivery
Xavier Trepat and the UPC’s Marino Arroyo had their turn at being profiled in La Vanguardia on Sunday as finalists in this year’s edition of the newspaper’s Science Award.
Vito Conte may be familiar to many, having spent more than four years in Xavier Trepat’s Integrative Cell and Tissue Dynamics group, first as a postdoc and later as a Juan de la Cierva fellow. Vito now is a Ramon y Cajal fellow and leads the Mechanics of Development and Disease group, which will take a new direction as he develops new biophysical tools to quantify the mechanics of cell and tissues in 3D environments.“With a strong background in studying how cell and tissue mechanics determine structure and function from my time as a postdoc, I want to carry on exploring the physical mechanisms of development and disease in biological organisms” says Vito, who completed his PhD in biomechanical engineering at King’s College London in the group of Prof. Mark Miodownik, now director of the Institute of Making at UCL. “To do this, my group will develop novel tools to carry out in vivo and in vitro mechanical measurements, which we will integrate into 2D and 3D models of the biological organisms being studied.”
Many drugs are hindered in their therapeutic potential by issues such as too-fast clearance by the kidneys, undesirable properties, lack of selectivity, and poor internalization in the cell. Nanotechnology has the potential to alter the landscape of medicine by providing targeted solutions for the delivery of small-molecule drugs and biopharmaceuticals.Now, new IBEC junior group leader Lorenzo Albertazzi and his former colleagues at the Eindhoven University of Technology, working together with industry partner Novartis, have made a leap in drug delivery vectors by developing a new type of carrier with some groundbreaking improvements.
Samuel Sánchez and Mykola Tasinkevych’s ‘microswimmers’ are usually guided through fluids using specially engineered magnetic multilayer coatings, which combined with external magnetic fields, helps to control their trajectory.
IBEC group leader and ICREA research professor Samuel Sánchez was one of two scientists taking part in a studio discussion on La Sexta Noche on Saturday, in a segment about what it’s like to be a talented young scientist or entrepreneur in the financial climate of Spain today.